About Eucare Pharmaceuticals P Ltd
Data last updated:
Eucare Pharmaceuticals P Ltd is a private limited company based in Tamil Nadu, India, a subsidiary of Hcp Healthcare Asia Pte. Ltd.. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 18 March 1996 and has been in existence for over 30 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24231TN1996PTC034848. Its GSTIN is 33AAACE2027L1ZZ (Tamil Nadu).
The company has an authorised share capital of ₹90 Lakh and a paid-up capital of ₹88.68 Lakh. It is led by directors including Pratik Santosh Bhide (Managing Director) and Guirec Le Lous.
Its last annual general meeting (AGM) was held on 10 July 2026, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Plotnoac25B Siidcoindustrialestate Thirumudivakkam Chennai – 44., Tamil Nadu, India.
As per the financials filed for FY 2026, the company reported a revenue of ₹38.35 Cr, a growth of 9% compared to the previous year. For the same year it recorded a net loss of ₹3.86 Cr (net margin -10.1%) and EBITDA of -₹22.17 Lakh (EBITDA margin -0.6%). Revenue has grown at a compounded annual rate (CAGR) of 22% over five years.
The company has about 140 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Eucare Pharmaceuticals. As per MCA filings, the company has open charges of ₹60 Lakh and satisfied charges of ₹5.79 Cr on record. Court records list 2 cases involving the company, including 1 filed by the company and 1 filed against it. The company has 7 deals on record (5 funding rounds, 2 secondary share transfers), with disclosed funding of ₹41.5 Lakh; the latest was in February 2016. Its 5 peer companies in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 2 larger and 3 smaller; the largest is Chemosyn Limited with revenue of ₹24.95 Cr. The company has 5 MSME Form 1 returns on record between 2019 and 2022, listing 113 overdue payments to 49 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website eucareindia.com.
Company details
Contact details
Eucare Pharmaceuticals P Ltd's registered office is in Tamil Nadu. Its website is eucareindia.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlotnoac25B Siidcoindustrialestate Thirumudivakkam Chennai – 44., Tamil Nadu, India
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Eucare Pharmaceuticals P Ltd, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Eucare Pharmaceuticals P operates one associated brand: Eucare Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Developer of collagen technologies and drug delivery systems | eucareindia.com |
Business activity
The main business activities of Eucare Pharmaceuticals P are manufacturing and trade. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and wholesale trading. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | |
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Eucare Pharmaceuticals P Ltd, buy the company report.
Financials of Eucare Pharmaceuticals P Ltd
FY 2026 filings availableEucare Pharmaceuticals P Ltd reported revenue of ₹38.35 Cr (up 9% YoY) for FY 2026.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 22% over five years, including 9% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹38.35 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹22.17 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹3.86 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -0.6% | ||||
| Net Profit Margin | -10.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Eucare Pharmaceuticals P Ltd, buy the company report.
Board of directors of Eucare Pharmaceuticals P Ltd
Eucare Pharmaceuticals P has 4 current directors and 13 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Guirec Le Lous | Director | 25 Nov 2019 | 6 Years 11 Months | Current |
| Gavin John Ashton | Director | 25 Nov 2019 | 6 Years 11 Months | Current |
| Pratik Santosh Bhide | Managing Director | 09 Jun 2022 | 4 Years 4 Months | Current |
| Javier Camps Hernan Perez | Director | 20 Jan 2025 | 1 Years 9 Months | Current |
Peer comparison
Eucare Pharmaceuticals P Ltd is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Eucare Pharmaceuticals P Ltdthis company | ₹38.35 Cr (FY 2026) | -₹3.86 Cr | -10.1% | 9.0% | 140 | Tamil Nadu, India |
| Chemosyn Limited | ₹24.95 Cr (FY 2025) | -22.0% | Mumbai, Maharashtra, India | |||
| Thrift Pharmaceuticals Private Limited | ₹24.95 Cr (FY 2024) | 11.0% | Vadodara, Gujarat, India | |||
| Pyxus Pharmaceuticals Private Limited | ₹24.91 Cr (FY 2025) | -4.0% | Ahmedabad, Gujarat, India | |||
| Artura Pharmaceuticals Private Limited | ₹24.89 Cr (FY 2024) | 37.0% | Chennai, Tamil Nadu, India | |||
| Sumit Pharmaceuticals Private Limited | ₹24.86 Cr (FY 2025) | 34.0% | Lucknow, Uttar Pradesh, India |
To see the full peer comparison of Eucare Pharmaceuticals P Ltd, buy the company report.
Auditor
Eucare Pharmaceuticals P Ltd is audited by Kalyaniwalla & Mistry LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Kalyaniwalla & Mistry LLP | FY 2023 | 104607W/W100166 |
Shareholding
The shareholding of Eucare Pharmaceuticals P Ltd is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Eucare Pharmaceuticals P Ltd, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 04 Jul 2020 | 100350476 | The Hongkong and Shanghai Banking Corporation Limited | ₹60 Lakh | Open | |
| 15 Oct 2007 | 10204394 | State Bank of India | ₹95.75 Lakh | Satisfied | |
| 10 Jan 2005 | 90294194 | State Bank of India | ₹4.95 Lakh | Satisfied | |
| 14 May 2004 | 90295214 | State Bank of India | ₹4.78 Cr | Satisfied |
To see the full charge records of Eucare Pharmaceuticals P Ltd, buy the company report.
Total charge records: 4 View all charges
Deals & funding
Eucare Pharmaceuticals P Ltd has 7 deals on record (5 funding rounds, 2 secondary share transfers), with disclosed funding of ₹41.5 Lakh; the latest was in February 2016.
Deals on record (5 of 7)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Feb 2016 | Funding round | ₹23.3 Lakh | Investors: Hcp Healthcare Asia Pte Limited |
| Mar 2013 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Jun 2012 | Funding round | ₹30,000 | Investors: an individual |
| Oct 2011 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Balaji Mariline Pvt Ltd |
| Mar 2009 | Funding round | ₹3.2 Lakh | Investors: 2 individuals |
To see the full deal history of Eucare Pharmaceuticals P Ltd, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Eucare Pharmaceuticals P Ltd has 2 court cases on record: 1 filed by Eucare Pharmaceuticals P, 1 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 1 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Kancheepuram, Tamil Nadu | Civil suit | Filed by the company against M/S.Human Bloscience India Ltd., Rep. by Managing Director | Disposed |
| District court, Chennai, Tamil Nadu | Motor accident claim | Filed against the company by an individual | Disposed |
To see the full case history of Eucare Pharmaceuticals P Ltd, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Eucare Pharmaceuticals P Ltd has 5 MSME Form 1 returns on record between 2019 and 2022, listing 113 overdue payments to 49 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 49)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| Artbot Advertising and Films Private Limited | |||
| an individual supplier | |||
| Coherent Market Insights Private Limited | |||
| Microtrol Sterilisation Services Pvt.Ltd. |
To see the full MSME payment records of Eucare Pharmaceuticals P Ltd, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Eucare Pharmaceuticals P Ltd has a workforce of 140 employees on its EPFO records as of Apr 05, 2024, across 1 active EPFO establishment.
GST
Eucare Pharmaceuticals P has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAACE2027L1ZZ | Tamil Nadu | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Eucare Pharmaceuticals P Ltd, buy the company report.
Recent activity
Eucare Pharmaceuticals P Ltd has 17 board changes on record since 2016: 4 appointments and 13 cessations. The latest: Javier Camps Hernan Perez was appointed as Director on 20 Jan 2025.
16 earlier events are in the company report.
Frequently asked questions
Eucare Pharmaceuticals P is an active private limited company based in Tamil Nadu, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 18 March 1996 (30+ years old) and is registered under CIN U24231TN1996PTC034848.
Eucare Pharmaceuticals P has 4 current directors:
- Pratik Santosh Bhide - Managing Director
- Guirec Le Lous - Director
- Gavin John Ashton - Director
- Javier Camps Hernan Perez - Director
The latest financial statements of Eucare Pharmaceuticals P on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 10 July 2026. Year-wise statements from 2015 are in the company report.
The GSTIN of Eucare Pharmaceuticals P is 33AAACE2027L1ZZ, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Eucare Pharmaceuticals P is U24231TN1996PTC034848. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Eucare Pharmaceuticals P has 2 court cases on record: 1 filed by the company and 1 filed against it.
Eucare Pharmaceuticals P was incorporated on 18 March 1996, making it 30+ years old. It is registered with the Registrar of Companies, Chennai.
Eucare Pharmaceuticals P has 7 deals on record (5 funding rounds, 2 secondary share transfers), with disclosed funding of ₹41.5 Lakh; the latest was in February 2016.
The peers of Eucare Pharmaceuticals P by revenue are Chemosyn Limited, Thrift Pharmaceuticals Private Limited, Pyxus Pharmaceuticals Private Limited, Artura Pharmaceuticals Private Limited, Sumit Pharmaceuticals Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Javier Camps Hernan Perez was appointed as Director on 20 Jan 2025. Ronan Jean Louis Blanchard ceased to be Director on 11 Oct 2024. Pratik Santosh Bhide ceased to be Additional Director on 22 Jun 2022. Eucare Pharmaceuticals P has 17 board changes on record in total.
Eucare Pharmaceuticals P has 5 MSME Form 1 returns on record between 2019 and 2022, listing 113 overdue payments to 49 micro and small suppliers. The latest return was filed on 28 Apr 2022.
Eucare Pharmaceuticals P can be reached through the website eucareindia.com. Its registered office is in Tamil Nadu, India.